This Article is no longer available, this page is showing similar articles.

Food, Drugs, Healthcare, Life Sciences

Subscribe

Welcome to the Mondaq Food, Drugs, Healthcare, Life Sciences homepage, here you will find thought leadership articles, podcasts, videos and webinars providing insights covering topics such as Food and Drugs Law, Healthcare, Life Sciences, Biotechnology and Nanotechnology.

Medicare Payment Suspensions Emerge As A Key Tool In Federal Anti-Fraud Efforts — Focus On California Hospices

The Trump Administration has signaled an aggressive stance on healthcare fraud enforcement, with Medicare payment suspensions emerging as a powerful tool to combat suspected fraud schemes.

United States Healthcare

FL

Foley & Lardner

Maine Health Care Transactions: New State Approvals Involving Some Private Equity, Hedge Funds, And MSOs

Two major developments are reshaping the legal landscape for healthcare and cannabis industries: the DEA's final order rescheduling certain marijuana products to Schedule III under the Controlled Substances Act, and Congress and the Trump Administration's intensified focus on combating fraud, waste, and abuse in healthcare. These policy shifts carry significant implications for pharmaceutical companies, cannabis businesses, healthcare providers, and regulatory compliance professionals navigating evolving fe

United States Healthcare

FL

Foley & Lardner

Pixels On Trial: Managing ECPA Exposure In Healthcare Web Tracking

Healthcare and healthcare-adjacent companies face a wave of litigation over ubiquitous website tracking technologies used for a range of analytics and advertising purposes.

United States Healthcare

SR

McDermott Will & Schulte

U.S. Health And Human Services Tries Again To Improve Availability Of Innovative Devices In Medicare

On April 23, 2026, the Centers for Medicare & Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced a plan to create a new pathway to expedite Medicare coverage for certain medical devices designated by the FDA as breakthrough devices (the Announcement).

United States Healthcare

AP

Arnold & Porter

CMS Proposes New Payment Policy For IOPOs And HCLs

United States Healthcare

CM

Crowell & Moring LLP

Cosmetics Industry Update: What’s New With MoCRA?

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

1x1 With Dr. Jessica Gaulton At FamilyWell

United States Healthcare

GP

Goodwin Procter LLP

OIG Approves Medicare Advantage EGWP Gainshare Payments To Employer Groups

United States Healthcare

BT

Barnes & Thornburg LLP

Maine Expands Health Care Transaction Oversight Through Dual Legislative Actions

United States Healthcare

M

Mintz

Podcast - Inside Telehealth's Growth, Regulation And Access

United States Healthcare

HK

Holland & Knight

Post‑Acquisition TSA Analytics Platform

United States Healthcare

AC

Ankura Consulting Group LLC

Is Anti-Steering Anticompetitive? Examining DOJ's Expanding Enforcement Against Hospital Contracting

United States Healthcare

BA

Bradley Arant Boult Cummings LLP

Navigating Health System Governance And Board Fiduciary Duties In Distressed Transactions

United States Healthcare

BT

Barnes & Thornburg LLP

HHS-OIG Issues Favorable Advisory Opinion on Cost-Sharing Waivers by Domestic Crisis Provider Serving Domestic Violence Survivors

United States Healthcare

BT

Barnes & Thornburg LLP

See more

Webinars

See More

Recorded on 20 Jan 2026 | 3:00 PM

2026 Canadian In-House Counsel Report: Unparalleled Insights into Canada's In-House Profession from CBA In-House Lawyers

TC

CBA In-House Lawyers

Recorded on 24 Jun 2025 | 3:00 PM

(2nd Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 24 Jun 2025 | 9:00 AM

(1st Session) 2025 Global In-House Counsel Survey Report: Unique Insights into the Global In-House Counsel Profession

IC

In-House Counsel Worldwide

Recorded on 30 Apr 2025 | 2:00 PM

Mondaq | 2025 Law Firm Data Landscape Report

mm

Mondaq

Highlighted Content

Plausibility At The EPO – An Update On G2/21

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In The United States Today?

United States Healthcare

D

Dehns

Infringement Of Repurposed Drug Patents And Skinny Labelling – Where Does The Balance Lie In Europe Today?

United States Healthcare

D

Dehns

How Good Does A Copy Need To Be?

United States Healthcare

D

Dehns

Supplementary Protection Certificates – European Patent Term Extensions

United States Healthcare

D

Dehns

How Much Experimental Data Is Needed For Patent Applications In Europe?

United States Healthcare

D

Dehns

The Silent Treatment: The EPO's Approach To Non-therapeutic Methods Encompassing Therapeutic Effects

United States Healthcare

D

Dehns

Implications Of The Genetic Technology (Precision Breeding) Bill On The Life Science IP Sector

United States Healthcare

D

Dehns

Protection For Plant Varieties In Europe And The UK Post-Brexit

United States Healthcare

D

Dehns

Best Practice For Invention Harvesting

United States Healthcare

D

Dehns

Food and Drugs Law

Rescheduling Happened: What State-Licensed Medical Cannabis Operators Need To Know And Do Immediately

The federal government has rescheduled medical marijuana, creating new compliance obligations for state-licensed operators. While this change eliminates Section 280E tax burdens and eases capital access...

United States Cannabis

BA

Bradley Arant Boult Cummings LLP

Alcohol Industry Update: Bribery Charges, New State Laws, And THC Uncertainty

March 2026 brought significant developments for alcoholic beverage suppliers, distributors, and retailers, including a major federal indictment involving alleged commercial bribery...

United States Cannabis

SR

McDermott Will & Schulte

DOJ Reschedules Certain Marijuana Products To Schedule III: What Employers Need To Know

Executive Summary: On April 22, 2026, the U.S. Department of Justice (DOJ) issued a final order (“Final Order”) placing FDA-approved drug products containing marijuana and medical marijuana products...

United States Employment

FH

Ford & Harrison LLP

Maine Health Care Transactions: New State Approvals Involving Some Private Equity, Hedge Funds, And MSOs

United States Healthcare

FL

Foley & Lardner

Cannabis Just Got Rescheduled. Sort Of.

United States Cannabis

FL

Fennemore

U.S. Health And Human Services Tries Again To Improve Availability Of Innovative Devices In Medicare

United States Healthcare

AP

Arnold & Porter

It's A Dog Eat Dog World

United States Media & IT

FK

Frankfurt Kurnit Klein & Selz

DOJ And DEA Order Immediately Reschedules FDA-Approved And State-Licensed Medical Cannabis To Schedule III: What Operators Need To Know

United States Cannabis

SH

Scarinci Hollenbeck LLC

From MAHA To Market - FDA And Some Retailers Announcing New Policies On Colors (Podcast)

United States Media & IT

KD

Kelley Drye & Warren LLP

See more

Life Sciences, Biotechnology & Nanotechnology

Why Patent Portfolios Are Crucial For Life Science Innovators

In the life sciences sector, securing funding and achieving market leadership requires more than groundbreaking innovation. Companies must implement strategic intellectual property...

United States IP

GT

Greenberg Traurig, LLP

U.S. Health And Human Services Tries Again To Improve Availability Of Innovative Devices In Medicare

On April 23, 2026, the Centers for Medicare & Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced a plan to create a new pathway to expedite Medicare coverage for certain medical devices designated by the FDA as breakthrough devices (the Announcement).

United States Healthcare

AP

Arnold & Porter

Teva v. Lilly: Limiting Amgen’s Reach On Written Description And Enablement

The Federal Circuit's decision in Teva Pharmaceuticals International GMBH v. Eli Lilly & Co. establishes a critical distinction in how written description and enablement requirements apply to method-of-use claims versus article claims for antibody patents. This case highlights the strategic complexities that arise when a defendant first argues a patent is obvious, then pivots to challenge its validity under Section 112, creating inherent tensions in litigation strategy.

United States IP

DS

Dinsmore & Shohl

DOJ And DEA Order Immediately Reschedules FDA-Approved And State-Licensed Medical Cannabis To Schedule III: What Operators Need To Know

United States Cannabis

SH

Scarinci Hollenbeck LLC

The Critical First 30 Days: A Defense Perspective On Managing Traumatic Accident Claims

United States Litigation

BI

Buchanan Ingersoll & Rooney PC

Cosmetics Industry Update: What’s New With MoCRA?

United States Healthcare

BI

Buchanan Ingersoll & Rooney PC

1x1 With Dr. Jessica Gaulton At FamilyWell

United States Healthcare

GP

Goodwin Procter LLP

Ambitious Priorities: Breaking Down FDA’s FY27 Budget

United States Healthcare

AG

Akin Gump Strauss Hauer & Feld LLP

Trans-Atlantic Alignment? US Federal Circuit Moves Closer To The EPO/UPC Approach For Broad Antibody Claims To Medical Uses

United States IP

JA

J A Kemp LLP

See more

Healthcare

Medicare Payment Suspensions Emerge As A Key Tool In Federal Anti-Fraud Efforts — Focus On California Hospices

The Trump Administration has signaled an aggressive stance on healthcare fraud enforcement, with Medicare payment suspensions emerging as a powerful tool to combat suspected fraud schemes.

United States Healthcare

FL

Foley & Lardner

Why Patent Portfolios Are Crucial For Life Science Innovators

In the life sciences sector, securing funding and achieving market leadership requires more than groundbreaking innovation. Companies must implement strategic intellectual property...

United States IP

GT

Greenberg Traurig, LLP

Pixels On Trial: Managing ECPA Exposure In Healthcare Web Tracking

Healthcare and healthcare-adjacent companies face a wave of litigation over ubiquitous website tracking technologies used for a range of analytics and advertising purposes.

United States Healthcare

SR

McDermott Will & Schulte

Maine Health Care Transactions: New State Approvals Involving Some Private Equity, Hedge Funds, And MSOs

United States Healthcare

FL

Foley & Lardner

U.S. Health And Human Services Tries Again To Improve Availability Of Innovative Devices In Medicare

United States Healthcare

AP

Arnold & Porter

OCR Announces HIPAA Enforcement Action Against Self-Funded Group Health Plan

United States Employment

JL

Jackson Lewis P.C.

DOJ And DEA Order Immediately Reschedules FDA-Approved And State-Licensed Medical Cannabis To Schedule III: What Operators Need To Know

United States Cannabis

SH

Scarinci Hollenbeck LLC

OIG Approves Medicare Advantage EGWP Gainshare Payments To Employer Groups

United States Healthcare

BT

Barnes & Thornburg LLP

Podcast - Inside Telehealth's Growth, Regulation And Access

United States Healthcare

HK

Holland & Knight

See more

Latest Videos

See more

PBM Reform 2026: What Recent Legislation Means For The Industry (Video)

M

Mintz

In The Know: The Clean Beauty Trend Becomes State Law (Video)

LL

Loeb & Loeb LLP

GT Legal Food Talk Episode 30: Navigating Liquor Licensing: Inside The Legal Food & Beverage Landscape (Podcast)

GT

Greenberg Traurig, LLP

Leaders In Law: Life Sciences And Technology Transactions With Jekkie Kim (Podcast)

W

WilmerHale

Digging Into New York's New Price-Gouging Rules (Video)

BS

Bond, Schoeneck & King PLLC

Upcoming Events

Operationalizing Legal Advice: The Role Of Attorneys In “Getting Things Done”

United States Healthcare

FL

Foley & Lardner

NACD New England Virtual M&A Program

United States Healthcare

M

Mintz

Consumer Chemistry: Classifying Personal Care And Home And Garden Products

United States Healthcare

BG

Braumiller Law Group, PLLC

BioNJ Partnering Conference

United States Healthcare

FH

Foley Hoag LLP

AHLA’s Annual Meeting & In-House Counsel Program

United States Healthcare

FL

Foley & Lardner

2026 Kayo Women's Healthcare Private Equity Summit

United States Healthcare

BB

Bass, Berry & Sims

Connect With Gowling WLG At BIO 2026

United States Healthcare

GW

Gowling WLG

Qui Tam & Civil False Claims And Healthcare Fraud Institute 2026

United States Healthcare

BB

Bass, Berry & Sims

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More